Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
12/1998
12/03/1998WO1998045712A3 20 human secreted proteins
12/03/1998WO1998042739A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998040486A3 Secreted proteins and polynucleotides encoding them
12/03/1998WO1998033916A3 Secreted proteins and polynucleotides encoding them
12/03/1998CA2291861A1 Zinc finger protein derivatives and methods therefor
12/03/1998CA2291482A1 Tissue plasminogen activator-like protease
12/03/1998CA2290682A1 Use of low-molecular-weight heparins for preventing and treating cerebral edemas
12/03/1998CA2289522A1 Use of oligosaccharide for preventing blood clotting in extracorporeal blood circuits
12/03/1998CA2288737A1 Pharmaceutical preparation comprising vwf propeptide
12/03/1998CA2287292A1 Sulfonamide derivatives, their production and use
12/02/1998EP0880591A1 Thrombin muteins as antidotes for thrombin inhibitors
12/02/1998EP0880524A1 New triazolopurines, method of preparing them and their use as drugs
12/02/1998EP0880511A1 Integrin receptor antagonists
12/02/1998EP0880502A1 Aminoheterocyclic derivatives as antithrombotic or anticoagulant agents
12/02/1998EP0880363A1 Combinations, having immunosuppressive effects, containing a cyclooxygenase-2 inhibitor and a leukotriene a 4? hydrolase inhibitor
12/02/1998EP0880362A1 Compositions comprising a cyclooxygenase-2 inhibitor and a leukotriene b 4 receptor antagonist
12/02/1998EP0691986B1 NOVEL PROCESSES AND INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF PLATELET CLYCOPROTEIN IIb/IIIa INHIBITORS
12/02/1998CN1200676A Pharmaceutical compositions contg. platelet aggregation inhibitors
12/02/1998CN1200366A Neo-L-threonic acid derivatives
12/01/1998US5844090 Modified hemoglobin-like compounds
12/01/1998US5844089 Genetically fused globin-like polypeptides having hemoglobin-like activity
12/01/1998US5844088 Hemoglobin-like protein comprising genetically fused globin-like polypeptides
12/01/1998US5843994 Compositions and methods for treating and preventing pathologies including cancer
12/01/1998US5843948 Piperazinophenyl- and piperazinophenyloxycarboxylic acid derivatives, and processes and intermediates for their preparation and pharmaceutical compositions comprising them
12/01/1998US5843914 Neurturin and related growth factors
12/01/1998US5843904 Inhibitors of interleukin-1βconverting enzyme
12/01/1998US5843895 Pharmaceutical administration of ecotin homologs
12/01/1998US5843888 Low oxygen affinity mutant hemoglobin
12/01/1998US5843438 Peripheralization of hematopoietic stem cells
12/01/1998US5843423 Methods of stimulating hematopoietic cells with flt3-ligand
11/1998
11/26/1998WO1998053050A2 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998WO1998052941A1 PYRAZOLE DERIVATIVES AS p38 KINASE INHIBITORS
11/26/1998WO1998052940A1 SUBSTITUTED PYRAZOLES AS p38 KINASE INHIBITORS
11/26/1998WO1998052937A2 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase
11/26/1998WO1998052599A1 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions
11/26/1998WO1998052598A1 Novel administration of thrombopoietin
11/26/1998WO1998030582A3 Secreted proteins and polynucleotides encoding them
11/26/1998CA2291115A1 Substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2290721A1 Short peptides which selectively modulate the activity of serine/threonine kinases
11/26/1998CA2288964A1 Novel administration of thrombopoietin
11/26/1998CA2288787A1 Pyrazole derivatives as p38 kinase inhibitors
11/26/1998CA2288741A1 4-aryl-3(5)-heteroaryl substituted pyrazoles as p38 kinase inhibitors
11/26/1998CA2261681A1 Atrial natriuretic peptide (anp) as an additive to peritoneal dialysis solutions
11/25/1998EP0879889A2 A novel member of the IL-1 family, IL-1 delta
11/25/1998EP0879883A1 ATG-1120 (AIF-1-DELTA), a splice variant of AIF-1/RC-9
11/25/1998EP0639202B1 Stable polypeptide composition
11/25/1998EP0624159B1 Pyridyl substituted imidazoles
11/25/1998EP0601043B1 Hybrid cytokines
11/25/1998CN1199641A Chinese medicine preparation for preventing and curing cerebral thrombus
11/25/1998CN1040874C Triazolopyridazine compounds and its preparation, composition with said compound as its active ingredient
11/24/1998US5840733 Argatroban derivatives which can be covalently linked to various blood components
11/24/1998US5840533 Tissue plasminogen activator
11/24/1998US5840299 Binding and treatment of multiple sclerosis
11/24/1998CA2108584C Substituted azetidinones as anti-inflammatory and antidegenerative agents
11/22/1998CA2231017A1 A member of the frzb family, frazzled
11/22/1998CA2221688A1 Atg-1120 (aif-1-delta), a novel splice variant of aif-1/rc-9
11/19/1998WO1998051689A1 A new process for the preparation of a pharmacologically active substance
11/19/1998WO1998051684A1 Antithrombotic compound
11/19/1998WO1998051665A2 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998WO1998051366A1 Method of removing thrombosis in fistulae
11/19/1998WO1998051335A1 Methods of modulating immune coagulation
11/19/1998WO1998051325A2 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998WO1998031802A3 Secreted proteins and polynucleotides encoding them
11/19/1998DE19821073A1 New sulphated vinyl (co)polymer heparin analogues
11/19/1998CA2290756A1 Random peptides that bind to gastro-intestinal tract (git) transport receptors and related methods
11/19/1998CA2289625A1 Antithrombotic compound
11/19/1998CA2289197A1 Apparatus for removing thrombosis in fistulae
11/19/1998CA2287923A1 Novel macrocyclic compounds as metalloprotease inhibitors
11/19/1998CA2221866A1 A novel member of the il-1 family, il-1 delta
11/18/1998EP0878542A2 cDNA clone HMTMF81 that encodes a novel human 7-transmembrane receptor
11/18/1998EP0878491A2 Heparin analogues homo- or copolymers, their preparation and their use
11/18/1998EP0878479A2 G-protein coupled receptor (HOFNH30)
11/18/1998EP0878201A1 Preventives and remedies for thrombocytopenia
11/18/1998EP0878195A1 Use of a 2-aroyl-3-arylbenzo(b)thiophene compound for reducing fibrinogen
11/18/1998EP0877753A1 Peptide inhibitors of hematopoietic cell proliferation
11/18/1998EP0877734A1 Quinoline and quinazoline compounds useful in therapy
11/18/1998EP0877626A2 Anti-cd18 antibodies for use against stroke
11/18/1998CN1199337A Method of inhibiting plasminogen activator inhibitor 1
11/18/1998CN1198946A 'Heilongzenghong' tablet for promoting thrombopoiesis and its compounding process
11/18/1998CN1040758C Process for preparation of crystalline fumarate of diazabiscyclic nonane
11/18/1998CN1040753C Pyridine derivs. and preparation process thereof
11/17/1998US5837842 Vascular anticoagulant proteins DNA which codes them, processer for preparing them and their use
11/17/1998US5837720 N-2-(pyrrolidinyl-1)-1-phenethyl) acetamides as kappa receptor antagonists
11/17/1998US5837717 Hydroxamic acid anesthetic compounds
11/17/1998US5837684 Peptides
11/17/1998US5837679 Blood coagulation factor for hemophelia
11/17/1998US5837490 Therapeutic, diagnostic, research uses
11/15/1998CA2237480A1 Heparin-analogous homo- or copolymers, their preparation and their use
11/13/1998CA2230971A1 G-protein coupled receptor (hofnh30)
11/12/1998WO1998050420A1 Serine protease inhibitors
11/12/1998WO1998032457A3 Method for promoting hematopoietic and mesenchymal cell proliferation and differentiation
11/12/1998CA2287569A1 Serine protease inhibitors
11/11/1998EP0877030A2 EPO primary response gene 1,(EPRG1)
11/11/1998EP0876396A1 MIMOTOPES AND ANTI-MIMOTOPES OF HUMAN PLATELET GLYCOPROTEIN Ib/IX
11/11/1998EP0876395A1 INHIBITORS OF INTERLEUKIN-1$g(b) CONVERTING ENZYME
11/11/1998EP0876152A1 Novel administration of thrombopoietin
11/11/1998EP0876151A1 Microencapsulated genetically engineered microorganisms for clinical application
11/11/1998EP0876140A2 Improved concentrated injection and infusion solutions for intravenous administration
11/11/1998EP0586381B1 Improved blood substitute
11/11/1998CN1198748A Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors